Evaluation of noncystic fibrosis bronchiectasis: six-year single center experience

F. ZIREK (ANKARA, Turkey), G. Özcan (ANKARA, Turkey), N. Çobanoglu (ANKARA, Turkey)

Source: Virtual Congress 2020 – Different aspects of paediatric viral and bacterial lung infections
Session: Different aspects of paediatric viral and bacterial lung infections
Session type: E-poster session
Number: 1158
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. ZIREK (ANKARA, Turkey), G. Özcan (ANKARA, Turkey), N. Çobanoglu (ANKARA, Turkey). Evaluation of noncystic fibrosis bronchiectasis: six-year single center experience. 1158

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Use of NIV in cystic fibrosis: 10-year experience of a large adult CF centre
Source: International Congress 2019 – Physiology of cystic fibrosis
Year: 2019

A ten year experience of non-cystic fibrosis bronchiectasis from a single center
Source: International Congress 2016 – Asthma, bronchiectasis, and the risk factors for respiratory morbidity
Year: 2016

Non cystic fibrosis bronchiectasis in a pediatric clinic – 5 year evaluation
Source: Eur Respir J 2006; 28: Suppl. 50, 490s
Year: 2006

A new paradigm for the management of children with cystic fibrosis at home: experiences from a Dutch cystic fibrosis clinic
Source: Virtual Congress 2021 – New technologies for the management of children with respiratory diseases
Year: 2021


Lung transplantation for Non- Cystic fibrosis bronchiectasis: A single centre retrospective analysis of 34 patients
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

The effect of transition from a paediatric to adult cystic fibrosis (CF) centre on clinical status and hospital attendance
Source: International Congress 2016 – From pleura to bronchi: new insights
Year: 2016

Non-cystic fibrosis bronchiectasis: series of 89 patients
Source: Annual Congress 2008 - Microbiology and treatment of bronchiectasis and exacerbations of COPD
Year: 2008


Pirfenidone in idiopathic pulmonary fibrosis - Real life experience from a german tertiary referral centre for interstitial lung diseases
Source: Annual Congress 2013 –Diffuse pulmonary fibrosis
Year: 2013

Inhaled mannitol in cystic fibrosis: clinical experience in Verona CF centre
Source: Virtual Congress 2020 – New insights into respiratory physiotherapy
Year: 2020


Clinical characteristics of patients with Idiopathic pulmonary fibrosis in a tertiary care center of a developing country
Source: International Congress 2016 – ILD: from the bench to the bedside
Year: 2016


Changing characteristics of childhood non-cystic fibrosis bronchiectasis
Source: Annual Congress 2011 - Innate and exogenous factors in childhood respiratory infection
Year: 2011

Lung transplant outcomes in bronchiectasis –a single center experience
Source: International Congress 2019 – Lung transplantation: from bench to bedside
Year: 2019

Prevalence of massive haemoptysis in cystic fibrosis: a six year review
Source: Annual Congress 2008 - Cystic fibrosis: factors affecting lung health
Year: 2008


Etiology and clinical outcome of pediatric non-cystic fibrosis bronchiectasis
Source: Annual Congress 2010 - Paediatric epidemiology: infection, prematurity and congenital abnormalities
Year: 2010


Efficacy of pirfenidone in idiopathic pulmonary fibrosis: A single center experience
Source: International Congress 2016 – IPF: from pathogenesis to treatment II
Year: 2016


Retrospective cohort study of adult cystic fibrosis patients colonised with achromobacter Xylosoxidans
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults
Year: 2013


The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis
Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021
Year: 2021



Pirfenidone in idiopathic pulmonary fibrosis (IPF): Early single centre Irish experience
Source: Annual Congress 2012 - Diffuse parenchymal lung disease III
Year: 2012